Relay Therapeutics, Inc. leads with RLY-2608, an allosteric PI3Kα inhibitor showing superior safety & efficacy. Learn more ...
New research reveals how tiny electrical gates in the brain, known as NMDA receptors, control learning, memory, and neuron survival.
News Medical on MSN
AI Revolutionizes Solid Tumor Drug Development
Artificial intelligence (AI) is fundamentally reshaping the landscape of solid tumor (ST) drug development. By integrating multi-omics data, spatial ...
Neuphoria Therapeutics Inc. ('Neuphoria” or the 'Company”) (Nasdaq: NEUP), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced that ...
Sudo Biosciences, ("Sudo"), a biopharmaceutical company committed to designing and developing best-in-class precision TYK2 (tyrosine kinase 2) inhibitors, today announced positive topline results from ...
RiPSIM Technologies, makers of the world's first cloud native software platform for generating and delivering mobile network authentication credentials on demand, today announced a strategic ...
BMS Presents Two Late-Breaking Presentations Demonstrating Sotyktu (deucravacitinib) Efficacy in Psoriatic Arthritis and Systemic Lupus Erythematosus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback